CNBP and breast cancer: In this sense, in breast cancer, mutations in P53 up-regulate components of the mevalonate pathway through the sterol regulatory element-binding protein (SREBP) family of transcription factors, increasing the flux in the mevalonate pathway of these mutants (75).